FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. (Q48306264)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. |
scientific article |
Statements
1 reference
FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. (English)
1 reference
Donald E Low
1 reference
Thomas M File
1 reference
Paul B Eckburg
1 reference
George H Talbot
1 reference
H David Friedland
1 reference
Jon Lee
1 reference
Lily Llorens
1 reference
Ian A Critchley
1 reference
Dirk A Thye
1 reference
FOCUS 2 investigators
1 reference
1 April 2011
1 reference
66 Suppl 3
1 reference
iii33-44
1 reference
Identifiers
1 reference
1 reference